maropitant - CISMeF

Preferred Label : maropitant;

MeSH note : neurokinin-1 receptor antagonist for treatment and prevention of emesis;

CISMeF synonym : (2S,2S)-2-benzhydryl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine citrate monohydrate; (2S,3S)-2-benzhydryl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine citrate monohydrate; maropitant citrate; 2-benzhydryl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine citrate monohydrate;

MeSH hyponym : (2S,3S)-2-benzhydryl-N-(5-(tert-butyl)-2-methoxybenzyl)quinuclidin-3-amine 2-hydroxypropane-1,2,3-tricarboxylate hydrate;

MeSH CAS label : 1-Azabicyclo(2.2.2)octan-3-amine, N-((5-(1,1-dimethylethyl)-2-methoxyphenyl)methyl)-2-(diphenylmethyl)-, (2S,3S)-;

MeSH Related Number : LXN6S3999X;

Is substance : O;

UNII : 4XE2T9H4DH;

InChIKey : OMPCVMLFFSQFIX-CONSDPRKSA-N;

Details

Origin ID

C518176;

UMLS CUI

C1871004;

Automatic exact mappings (from CISMeF team)
- Maropitant Citrate [NCIt concept]
- Product containing maropitant (medicinal product) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Maropitant [NCIt concept]
- Maropitant (substance) [SNOMED CT concept]
MeSH term(s) associated for indexing
- quinuclidines [MeSH Descriptor]
Pharmacological action(s)
- antiemetics [MeSH Descriptor]
- peripheral nervous system agents [MeSH Descriptor]
Record concept(s)
- (2S,2S)-2-benzhydryl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine citrate monohydrate [MeSH concept]
- (2S,3S)-2-benzhydryl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine citrate monohydrate [MeSH concept]
- 2-benzhydryl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine citrate monohydrate [MeSH concept]
- maropitant [MeSH concept]
- maropitant citrate [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Maropitant [NCIt concept]
- Maropitant (substance) [SNOMED CT concept]
- Product containing maropitant (medicinal product) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients